Skip to main content

Table 2 Changes in mental health and social functioning over six months

From: Severe COVID anxiety among adults in the United Kingdom: cohort study and nested feasibility trial

Variable

Timepoint

n

Mean ± SD

Change

Mean (95% CI)

p-value vs. baseline

CAS

Baseline

285

12.4 ± 3.0

0

 

3 months

177

7.7 ± 4.4

-4.7 (-5.2, -4.1)

 < 0.001

6 months

204

6.8 ± 4.5

-5.5 (-6.0, -4.9)

 < 0.001

WSAS

Baseline

267

21.3 ± 7.7

0

 

3 months

169

19.0 ± 9.0

-2.7 (-3.9, -1.5)

 < 0.001

6 months

203

18.3 ± 9.0

-3.4 (-4.5, -2.3)

 < 0.001

GAD-7

Baseline

274

15.4 ± 4.0

0

 

3 months

172

13.4 ± 5.0

-2.2 (-2.9, -1.5)

 < 0.001

6 months

203

12.5 ± 5.5

-3.0 (-3.7, -2.3)

 < 0.001

sHAI

Baseline

269

23.2 ± 7.1

0

 

3 months

171

21.7 ± 8.5

-1.8 (-2.6, -0.9)

 < 0.001

6 months

203

19.7 ± 8.4

-3.5 (-4.3, -2.7)

 < 0.001

PHQ-9

Baseline

268

15.6 ± 5.5

0

 

3 months

170

13.8 ± 6.4

-1.5 (-2.3, -0.7)

 < 0.001

6 months

203

13.4 ± 6.7

-2.1 (-2.9, -1.4)

 < 0.001

OCI-R

Baseline

264

30.4 ± 15.3

0

 

3 months

169

28.2 ± 16.8

-1.5 (-3.2, 0.2)

0.09

6 months

203

25.9 ± 15.5

-4.1 (-5.7, -2.5)

 < 0.001

AUDIT-C

Baseline

264

2.66 ± 2.97

0

 

3 months

173

2.48 ± 2.77

0.03 (-0.22, 0.28)

0.81

6 months

204

2.41 ± 2.62

0.02 (-0.22, 0.25)

0.88

Variable

Timepoint

n

n (%)

Odds Ratio

(95% CI)

p-value vs. baseline

Drug use

Baseline

264

24 (9.1%)

1

 

3 months

173

12 (6.9%)

0.61 (0.18, 2.04)

0.42

6 months

204

20 (9.8%)

1.62 (0.58, 4.52)

0.35